Visual event-related potential changes at two different tasks in nondemented Parkinson's disease

Journal of the Neurological Sciences

Volumn 164, Issue 2, 1999, Pages 139-147

  Wang, L ^a   Kuroiwa, Y ^a   Kamitani, T ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Event related potential; Motor disability; N200; Oddball paradigm; P300; Parkinson's disease; S1 S2 paradigm; WAIS R

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; EVOKED VISUAL RESPONSE; HUMAN; MOTOR DYSFUNCTION; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL;

AGE OF ONSET; AGED; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REACTION TIME; REFERENCE VALUES; TIME FACTORS;

EID: 0033121183     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00060-X     Document Type: Article

References (36)

1. Brown R.G., Marsden C.D. How common is dementia in Parkinson's disease? Lancet. 2:1984;1262-1265.
2. Pirozzolo F.J., Hansch E.C., Mortimer J.A., Webster D.D., Kuskowski M.A. Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn. 1:1982;71-83.
3. Koller W.C., Silver D.E., Lieberman A. An algorithm for the management of Parkinson's disease. Neurology. 44:(10):1994;1-52.
4. Kutas M., McCarthy G., Donchin E. Augmenting mental chronmetry: the P300 as a measure of stimulus evaluation time. Science. 197:1977;792-795.
5. Hansch E.C., Syndulko K., Cohen S.N., Goldberg Z.I., Potvin A.R., Tourtellotte W.W. Cognition in Parkinson disease: an event-related potential perspective. Ann Neurol. 11:1982;599-607.
6. Prasher D., Findley L. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. J Neurol Neurosurg Psychiatry. 54:1991;603-609.
7. Hayashi R., Hanyu N., Shindo M., Tamaru F., Yanagisawa N. Event-related potentials, reaction time and cognitive state in patients with Parkinson's disease. Adv Neurol. 60:1993;429-433.
8. Aotsuka A., Weate S.J., Drake M.E., Paulson G.W. Event-related potentials in Parkinson's disease. Electromyogr Clin Neurophysiol. 36:1996;215-220.
9. Elwan O.H., Baradah O.H., Madkour O., Elwan H., Hassan A.A., Elwan F., Mahfouz M., Ali A., Fahmy M. Parkinson's disease, cognition and aging. Clinical, neuropsychological, electrophysiological and cranial computerized tomographic assessment. J Neurol Sci. 143:1996;64-71.
10. Tachibana H., Aragane K., Kawabata K., Sugita M. P3 latency change in aging and Parkinson disease. Arch Neurol. 54:1997;296-302.
11. Goodin D.S., Aminoff M.J. Electrophysiological differences between demented and nondemented patients with Parkinson's disease. Ann Neurol. 21:1987;90-94.
12. Stanzione P., Fattapposta F., Giunti P., D'Alessio C., Tagliati M., Affricano C., Amabile G. P300 variations in Parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalogr Clin Neurophysiol. 80:1991;446-453.
13. Rumbach L., Tranchant C., Viel J.F., Warter J.M. Event-related potentials in Parkinson's disease: a 12-month follow-up study. J Neurol Sci. 116:1993;148-151.
14. Green J., Woodard J.L., Sirockman B.E., Zakers G.O., Maier C.L., Green R.C., Watts R.L. Event-related potential P3 change in mild Parkinson's disease. Mov Disord. 11:1996;32-42.
15. Hely M.A., Morris J.G., Reid W.G., O'Sullivan D.J., Williamson P.M., Broe G.A., Adena M.A. Age at onset: the major determinant of outcome in Parkinson's disease. Acta Neurol Scand. 92:1995;455-463.
16. Stanzione P., Semprini R., Pierantozzi M., Santili A.M., Fadda L., Traversa R., Peppe A., Bernardi G. Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy. Electroencephalogr Clin Neurophysiol. 108:1998;80-91.
17. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 55:1992;181-184.
18. Mizuno Y. Clinical assessment of Parkinsonism. Neuropsychol Pharmcol. 9:1987;103-111.
19. Tachibana H., Toda K., Sugita M. Event-related potentials in patients with multiple lacunar infarcts. Gerontology. 38:1992;322-329.
20. Begleiter H., Porjesz B., Wang W. A neurophysiologic correlate of visual short-term memory in humans. Electroencephalogr Clin Neurophysiol. 87:1993;46-53.
21. Bodis-Wollner I., Borod J.C., Cicero B., Haywood C.S., Raskin S., Mylin L., Sliwinski M., Falk A., Yahr M.D. Modality dependent changes in event-related potentials correlate with specific cognitive functions in non-demented patients with Parkinson's disease. J Neural Transm Park Dis Dement Sect. 9:1995;197-209.
22. Antal A., Pfeiffer R., Bodis-Wollner I. Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease. J Neural Transm. 103:1996;1053-1067.
23. Sagliocco L., Bandini F., Pierantozzi M., Mari Z., Tzelepi A., Ko C., Gulzar J., Bodis-Wollner I. Electrophysiological evidence for visuocognitive dysfunction in younger non Caucassian patients with Parkinson's disease. J Neural Transm. 104:1997;427-439.
24. Paz-Caballero M.D., Garcia-Austt E. ERP components related to stimulus selection processes. Electroencephalogr Clin Neurophysiol. 82:1992;369-376.
25. Ritter W., Simson R., Vaughan H.G. Event-related potential correlates of two stages of information processing in physical and semantic discrimination tasks. Psychophysiology. 20:1983;168-179.
26. Dubois B., Pillon B., Sternic N., Lhermitte F., Agid Y. Age-induced cognitive disturbances in Parkinson's disease. Neurology. 40:1990;38-41.
27. Goetz C.G., Tanner C.M., Stebbins G.T., Buchman A.S. Risk factors for progression in Parkinson's disease. Neurology. 38:1988;1841-1844.
28. Diamond S.G., Markham G.H., Hoehn M.M., McDowell F.H., Muenter M.D. Effect of age at onset on progression and mortality in Parkinson's disease. Neurology. 39:1989;1187-1190.
29. Neshige R., Barrett G., Shibasaki H. Auditory long latency event-related potentials in Alzheimer's disease and multi-infarct dementia. J Neurol Neurosurg Psychiatry. 51:1988;1120-1125.
30. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 114:1991;2095-2122.
31. Agid Y., Graybiel A.M., Ruberg M., Hirsch E., Blin J., Dubois B., Javoy-Agid F. The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role? Adv Neurol. 53:1990;83-100.
32. Dubois B., Pillon B. Cognitive deficits in Parkinson's disease. J Neurol. 244:1997;2-8.
33. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 275:1983;321-328.
34. Gaspar P., Duyckaerts C., Alvarez C., Javoy-Agid F., Berger B. Alterations of dopaminergic and nonadrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol. 30:1991;365-374.
35. Stern Y., Mayeux R., Cote L. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Arch Neurol. 41:1984;1086-1089.
36. Pillon B., Dubois B., Cusimano G., Bonnet A.M., Lhermitte F., Agid Y. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions? J Neurol Neurosurg Psychiatry. 52:1989;201-206.